• Led development of US strategic vision and plans to increase disease awareness of rare disease, supporting market leadership and product differentiation for Amvuttra® (vutrisiran) and Onpattro® (patisiran)• Developed and led launch readiness efforts as US launch lead, managing a cross-functional launch team, defining launch performance KPIs, presenting launch strategy and process to executive leadership, and facilitating decision-making forums• Partnered with global marketing team to ensure global launch strategy accounted for US market specificities, preparing organization for first launch into a competitive, prevalent cardiovascular market• Served as core member of the US marketing team, leading franchise strategy to align all marketing initiatives with overall franchise goals through close partnership with HCP and patient marketing teams• Supported development and facilitation of competitive readiness exercises, preparing organization for various future scenarios, including increased competition, evolving payer landscape, generic entrants, and future competitive product launches within neurology and cardiology space

• Supported preparation of second indication US launch strategy for Bylvay® (odevixibat) with HCP tactical planning, building and executing full HCP marketing mix to drive brand growth and portfolio development• Led development and design of franchise portfolio—both branded and unbranded—supporting field force efforts through disease state education and awareness, peer-to-peer education, non-personal promotion, advisory boards, publications, HCP media, and other digital channels• Directed internal plan-of-action (POA) meetings and annual brand planning efforts for US region• Drove expansion of US HCP targeting and developed HCP adoption and brand advocacy targeting framework• Oversaw budget process, achieving overall expense forecast accuracy each year• Managed and supported development of marketing product manager

• Led development of US and global brand strategies and HCP marketing tactical plans by assimilating input from across functions and regions to build the organization’s first commercial launch plan in rare diseases• Headed global commercial launch team, ensuring launch preparations remained on track and opportunities and issues were identified and addressed across functions and regions with clear communication• Built promotional platform, including brand messaging and creative campaign, along with a full range of omnichannel marketing programs and materials that drove competitive differentiation and patient identification targeting pediatric hepatologists and gastroenterologists aligned to US and EU brand strategy• Developed commercial plans, in collaboration with medical affairs, to lead and execute a comprehensive KOL engagement plan, global steering committee, speaker bureau, and presence at key medical congresses in the US and global• Hired, managed, and developed product manager that supported the execution of annual tactical plans• Partnered with commercial analytics to ensure planning and execution of all market research projects

Market Development• Led overall execution of branded and unbranded speaker bureau - including content approval, speaker credentialing, training, utilization, and a metrics assessment - in a co-promote environment (Regeneron)• Supported development, execution, and evaluation of strategic marketing tactics associated with medical congresses and field-based thought leader liaisons (TLLs) in line with the life cycle management plan• Interfaced with national thought leaders to deliver differentiated disease state education resources to support market development objectives for immunology specialists within allergy, pulmonary, and ENT• Collaborated with sales, medical affairs, legal, and regulatory to ensure cross-functional alignment and execution of key priorities and served as the team champion to process and lead projects through the Regulatory and Compliance Joint Review Committee• Recipient of the 2019 Individual Collaboration Award

HCP Marketing• Executed brand strategy through all field force initiatives for launch brand Dupixent® (dupilumab) in a highly competitive, prevalent biologics market within the immunology space targeting allergist and pulmonologists• Led business planning and execution efforts across a complex alliance environment through a multiple phased business planning initiative across all functions, to ensure teams were set up for success and allowed immediate action in execution of strategy and accountability across the organization upon FDA approval• Organized and led consistent communication touch points across all levels of sales to ensure a successful execution of all launch planning priorities and tactics, as well as sales training to best prepare the field to deliver on strategy• Optimized launch efforts by leading the planning and execution of pre-launch meetings, including serving as brand lead for strategic vision, meeting objectives, and agenda for a national pre-PDUFA launch meeting• Supported development of Day 1/Launch HCP materials across the alliance and led the process to push them live to ensure the sales force had all appropriate resources (print and digital) to execute the business plans

Portfolio Marketing • Supported strategic design of franchise portfolio - Firazyr® (icatibant injection), CINRYZE® (C1 esterase inhibitor [human]), and Kalbitor® (ecallantide) - and led execution of HCP and patient tactics across all marketing channels targeting allergists and immunologists to drive portfolio growth in rare genetic diseaseHCP Marketing• Supported HCP strategy and led tactical execution and management of all HCP assets and lead-generating initiatives, including conferences, national Pri-Med events, and regional Medical Mystery programs, while serving as the brand lead to external agencies and internal stakeholders to ensure execution excellencePatient Marketing• Supported patient marketing team in execution of the branded strategy and tactics, while leading unbranded efforts by driving disease state awareness through key advocacy, speaker bureau, and social channels

• Growth driver for seven brands within five different disease states across Allergists, ENTs, Pediatricians, and PCPs Awards: Circle of Excellence (Top 20% in Nation) winner for overall sales performanceWinner of the Pharma District MVP Award selected by Leadership with peer input#3 ranking nationwide in the Anti-Allergy market with 132% of goal Multiple Achievement Award recipient for Highest Market Share Increase in District